GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs – Investor’s Business Daily

0
24
GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs – Investor’s Business Daily

Gilead Sciences’ coronavirus treatment, remdesivir, could capture nearly $8 billion in 2022 sales, an analyst said Wednesday as he upgraded GILD stock.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here